Patents, Bio Rad Laboratories Inc, 10x Genomics, Microfluidics, Single Cell Sequencing.
genomics dating back to 2015. In November 2018, the jury found 10X guilty of infringing the patents at issue and awarded Bio-Rad $23.8 million in damage. In July 2019, Bio-Rad’s request for permanent injunction of the infringing product was approved by the presiding judge. The defeat effectively